Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-14
4:21 pm
Sale
13GNeoleukin Therapeutics, Inc.
NLTX
Redmile Group LLC3,030,566
6.9%
-1,290,994decrease
(-29.87%)
View
2023-02-03
11:56 am
Sale
13GNeoleukin Therapeutics, Inc.
NLTX
PICTET ASSET MANAGEMENT SA0
0%
-2,574,289decrease
(Position Closed)
View
2023-01-19
4:10 pm
Sale
13GNeoleukin Therapeutics, Inc.
NLTX
MILLENNIUM MANAGEMENT LLC1,587,267
3.7%
-545,319decrease
(-25.57%)
View
2022-12-30
4:29 pm
Purchase
13GNeoleukin Therapeutics, Inc.
NLTX
Lynx1 Capital Management LP2,291,133
5.38%
2,291,133increase
(New Position)
View
2022-07-19
4:08 pm
Purchase
13GNeoleukin Therapeutics, Inc.
NLTX
MILLENNIUM MANAGEMENT LLC2,132,586
5%
21,165increase
(+1.00%)
View
2022-07-15
4:04 pm
Sale
13GNeoleukin Therapeutics, Inc.
NLTX
MILLENNIUM MANAGEMENT LLC2,111,421
4.97%
-5,386decrease
(-0.25%)
View
2022-07-08
4:57 pm
Sale
13GNeoleukin Therapeutics, Inc.
NLTX
BlackRock Inc.
BLK
910,832
2.1%
-1,693,813decrease
(-65.03%)
View
2022-07-07
4:56 pm
Purchase
13GNeoleukin Therapeutics, Inc.
NLTX
MILLENNIUM MANAGEMENT LLC2,116,807
4.98%
2,116,807increase
(New Position)
View
2022-02-14
5:07 pm
Purchase
13GNeoleukin Therapeutics, Inc.
NLTX
Redmile Group LLC4,321,560
9.9%
125,902increase
(+3.00%)
View
2022-02-14
3:03 pm
Sale
13GNeoleukin Therapeutics, Inc.
NLTX
EcoR1 Capital LLC860,619
2%
-2,262,085decrease
(-72.44%)
View
2022-02-11
4:06 pm
Sale
13GNeoleukin Therapeutics, Inc.
NLTX
Silva Manzano Daniel Adriano2,909,168
6.8%
-28,978decrease
(-0.99%)
View
2022-02-11
4:06 pm
Purchase
13GNeoleukin Therapeutics, Inc.
NLTX
Ulge Umut3,127,733
7.3%
182,292increase
(+6.19%)
View
2022-02-10
11:10 am
Purchase
13GNeoleukin Therapeutics, Inc.
NLTX
PICTET ASSET MANAGEMENT SA2,574,289
6.07%
2,574,289increase
(New Position)
View
2022-02-02
7:18 pm
Sale
13GNeoleukin Therapeutics, Inc.
NLTX
BlackRock Inc.
BLK
2,604,645
6.1%
-80,265decrease
(-2.99%)
View
2021-02-16
4:10 pm
Purchase
13GNeoleukin Therapeutics, Inc.
NLTX
Redmile Group LLC4,195,658
9.9%
4,195,658increase
(New Position)
View
2021-02-16
12:05 pm
Sale
13GNeoleukin Therapeutics, Inc.
NLTX
EcoR1 Capital LLC3,122,704
7.5%
-793,176decrease
(-20.26%)
View
2021-02-12
4:27 pm
Sale
13GNeoleukin Therapeutics, Inc.
NLTX
Ulge Umut2,945,441
6.98%
-166,455decrease
(-5.35%)
View
2021-02-12
4:25 pm
Sale
13GNeoleukin Therapeutics, Inc.
NLTX
Silva Manzano Daniel Adriano2,938,146
6.96%
-173,750decrease
(-5.58%)
View
2021-02-02
3:13 pm
Purchase
13GNeoleukin Therapeutics, Inc.
NLTX
BlackRock Inc.
BLK
2,684,910
6.4%
1,670,613increase
(+164.71%)
View
2020-12-23
5:11 pm
Purchase
13DNeoleukin Therapeutics, Inc.
NLTX
BAKER BROS. ADVISORS LP4,229,827
9.99%
424,827increase
(+11.16%)
View
Goto 0, 1, Next